Showing results (1-10 of 488) with videos related to
Sort By:
Pageof 49
Current Opinion in Molecular Therapeutics|June 28, 2005
Hypertension pharmacogenomics: current status and future directionsJulie A Johnson, Stephen T TurnerKidney & Blood Pressure Research|June 13, 2012
Urate transporter gene SLC22A12 polymorphisms associated with obesity and metabolic syndrome in Caucasians with hypertensionMohamed Shafiu, Richard J Johnson, Stephen T Turner, et al.Pharmacogenomics|January 9, 2003
Genetics of blood pressure, hypertensive complications, and antihypertensive drug responsesStephen T Turner, Eric BoerwinkleJournal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Genetics of leukoaraiosisStephen T Turner, Myriam FornageJournal of Clinical Hypertension (Greenwich, Conn.)|January 6, 2010
Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazideAmber L Beitelshees, Yan Gong, Kent R Bailey, et al.Pharmacogenetics and Genomics|June 18, 2010
Lack of association between polymorphisms in STK39, a putative thiazide response gene, and blood pressure response to hydrochlorothiazideJulio D Duarte, Maximilian T Lobmeyer, Zhiying Wang, et al.Pharmacotherapy|August 28, 2010
Atenolol exposure and risk for development of adverse metabolic effects: a pilot studyHrishikesh A Navare, Reginald F Frye, Rhonda M Cooper-Dehoff, et al.Pharmacogenomics|May 9, 2013
Pharmacogenetics in clinical practice: how far have we come and where are we going?Julie A JohnsonPharmacogenomics|March 31, 2010
Pharmacogenomics of antihypertensive drugs: past, present and futureJulie A JohnsonAnnals of Medicine|June 21, 2012
Advancing management of hypertension through pharmacogenomicsJulie A JohnsonPageof 49